Literature DB >> 23563812

Type 2 innate lymphocytes in allergic airway inflammation.

Roel G J Klein Wolterink1, Rudi W Hendriks.   

Abstract

CD4(+) T helper-2 (Th2) cells, which produce a unique profile of IL-4, IL-5 and IL-13 pro-inflammatory cytokines, are thought to be central in the orchestration and amplification of allergic asthma. However, a novel non-T/non-B lymphoid cell population, named type 2 innate lymphocytes (ILC2s), that produces high amounts of IL-5 and IL-13 was recently discovered. Unlike Th2 cells, these ILC2s are not antigen-restricted and are activated by epithelial cell-derived cytokines IL-25 and IL-33. In this review, we will focus on recent studies, mainly involving allergen-based mouse models, that have provided evidence for a significant contribution of ILC2 to allergic airway information.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563812     DOI: 10.1007/s11882-013-0346-z

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  97 in total

Review 1.  The link between fungi and severe asthma: a summary of the evidence.

Authors:  D W Denning; B R O'Driscoll; C M Hogaboam; P Bowyer; R M Niven
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

2.  Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice.

Authors:  Koubun Yasuda; Taichiro Muto; Tatsukata Kawagoe; Makoto Matsumoto; Yuki Sasaki; Kazufumi Matsushita; Yuko Taki; Shizue Futatsugi-Yumikura; Hiroko Tsutsui; Ken J Ishii; Tomohiro Yoshimoto; Shizuo Akira; Kenji Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-13       Impact factor: 11.205

3.  The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.

Authors:  Gaby Palmer; Brian P Lipsky; Molly D Smithgall; David Meininger; Sophia Siu; Dominique Talabot-Ayer; Cem Gabay; Dirk E Smith
Journal:  Cytokine       Date:  2008-05-02       Impact factor: 3.861

4.  Regulation of IL-9 expression by IL-25 signaling.

Authors:  Pornpimon Angkasekwinai; Seon Hee Chang; Manoj Thapa; Hiroshi Watarai; Chen Dong
Journal:  Nat Immunol       Date:  2010-02-14       Impact factor: 25.606

5.  Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities.

Authors:  Erika A Rickel; Lori A Siegel; Bo-Rin Park Yoon; James B Rottman; David G Kugler; David A Swart; Penny M Anders; Joel E Tocker; Michael R Comeau; Alison L Budelsky
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

6.  Pulmonary IL-17E (IL-25) production and IL-17RB+ myeloid cell-derived Th2 cytokine production are dependent upon stem cell factor-induced responses during chronic allergic pulmonary disease.

Authors:  Vladislav Dolgachev; Bryan C Petersen; Alison L Budelsky; Aaron A Berlin; Nicholas W Lukacs
Journal:  J Immunol       Date:  2009-10-14       Impact factor: 5.422

7.  Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.

Authors:  Hye Young Kim; Ya-Jen Chang; Srividya Subramanian; Hyun-Hee Lee; Lee A Albacker; Ponpan Matangkasombut; Paul B Savage; Andrew N J McKenzie; Dirk E Smith; James B Rottman; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2011-11-25       Impact factor: 10.793

8.  Transcription factor RORα is critical for nuocyte development.

Authors:  See Heng Wong; Jennifer A Walker; Helen E Jolin; Lesley F Drynan; Emily Hams; Ana Camelo; Jillian L Barlow; Daniel R Neill; Veera Panova; Ute Koch; Freddy Radtke; Clare S Hardman; You Yi Hwang; Padraic G Fallon; Andrew N J McKenzie
Journal:  Nat Immunol       Date:  2012-01-22       Impact factor: 25.606

9.  IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease.

Authors:  Christian Taube; Christine Tertilt; Gabor Gyülveszi; Nina Dehzad; Katharina Kreymborg; Kristin Schneeweiss; Erich Michel; Sebastian Reuter; Jean-Christophe Renauld; Danielle Arnold-Schild; Hansjörg Schild; Roland Buhl; Burkhard Becher
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

10.  Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity.

Authors:  Hong-Erh Liang; R Lee Reinhardt; Jennifer K Bando; Brandon M Sullivan; I-Cheng Ho; Richard M Locksley
Journal:  Nat Immunol       Date:  2011-12-04       Impact factor: 25.606

View more
  17 in total

1.  Prolonged activation of IL-5-producing ILC2 causes pulmonary arterial hypertrophy.

Authors:  Masashi Ikutani; Koichi Tsuneyama; Makoto Kawaguchi; Junya Fukuoka; Fujimi Kudo; Susumu Nakae; Makoto Arita; Yoshinori Nagai; Satoshi Takaki; Kiyoshi Takatsu
Journal:  JCI Insight       Date:  2017-04-06

2.  Relationships among aeroallergen sensitization, peripheral blood eosinophils, and periostin in pediatric asthma development.

Authors:  Halie M Anderson; Robert F Lemanske; Joseph R Arron; Cecile T J Holweg; Victoria Rajamanickam; Ronald E Gangnon; James E Gern; Daniel J Jackson
Journal:  J Allergy Clin Immunol       Date:  2016-07-05       Impact factor: 10.793

3.  PGI2 Controls Pulmonary NK Cells That Prevent Airway Sensitization to House Dust Mite Allergen.

Authors:  Bryan Simons; Maria E Ferrini; Sophia Carvalho; David J P Bassett; Zeina Jaffar; Kevan Roberts
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

Review 4.  Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease.

Authors:  Maya R Karta; David H Broide; Taylor A Doherty
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

Review 5.  Group 2 innate lymphoid cells in lung inflammation.

Authors:  Bobby W S Li; Rudi W Hendriks
Journal:  Immunology       Date:  2013-11       Impact factor: 7.397

6.  Repeated Mouse Lung Exposures to Stachybotrys chartarum Shift Immune Response from Type 1 to Type 2.

Authors:  Jamie H Rosenblum Lichtenstein; Ramon M Molina; Thomas C Donaghey; Yi-Hsiang H Hsu; Joel A Mathews; David I Kasahara; Jin-Ah Park; André Bordini; John J Godleski; Bruce S Gillis; Joseph D Brain
Journal:  Am J Respir Cell Mol Biol       Date:  2016-10       Impact factor: 6.914

7.  Modulation of Signal Strength Switches Notch from an Inducer of T Cells to an Inducer of ILC2.

Authors:  Rebecca Gentek; J Marius Munneke; Christina Helbig; Bianca Blom; Mette D Hazenberg; Hergen Spits; Derk Amsen
Journal:  Front Immunol       Date:  2013-10-22       Impact factor: 7.561

8.  Interleukin 13-positive mast cells are increased in immunoglobulin G4-related sialadenitis.

Authors:  Mai Takeuchi; Kyotaro Ohno; Katsuyoshi Takata; Yuka Gion; Tomoyasu Tachibana; Yorihisa Orita; Tadashi Yoshino; Yasuharu Sato
Journal:  Sci Rep       Date:  2015-01-09       Impact factor: 4.379

Review 9.  Role of Interleukin-1 Receptor-Like 1 (ST2) in Cerebrovascular Disease.

Authors:  Cristina Sastre; Matthew B Bevers; W Taylor Kimberly
Journal:  Neurocrit Care       Date:  2021-07-06       Impact factor: 3.210

10.  Type 2 Innate Lymphoid Cells in Allergic Disease.

Authors:  Sean Lund; Hannah H Walford; Taylor A Doherty
Journal:  Curr Immunol Rev       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.